Clinical results with Omni-Orthocor, an implantable antitachycardia pacing system.
Omni-Orthocor 234A and 239A are implantable pacers capable of synchronization with an external overdriver. Synchronous or asynchronous burst pacing, synchronized extrastimuli, or a combination of both can be obtained. Upon recognition of a tachycardia, the patient or physician can initiate pace-termination. Omni-Orthocor was implanted in 69 patients (53 for ventricular tachycardia, 11 for supraventricular tachycardia, 2 each with AV nodal reentry and WPW, and 1 patient with concealed accessory pathway). Thirty-five patients performed out of hospital termination. More resistant tachycardias were terminated in the hospital with 76.3% success in VT and only 50% success for SVT. Burst pacing was used in 75% of patients. Noninvasive electrophysiologic study was performed on all patients, and was the sole use of Omni-Orthocor in 20 patients. The device was not implicated in the six sudden death patients in this series.
D000328:Adult; D000368:Aged; D001283:Atrioventricular Node / Q000503:physiopathology; D004567:Electrodes, Implanted; D004594:Electrophysiology / Q000295:instrumentation; D005260:Female; D005500:Follow-Up Studies; D006325:Heart Atria / Q000503:physiopathology; D006352:Heart Ventricles / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010138:Pacemaker, Artificial; D013610:Tachycardia / Q000503:physiopathology / Q000628:therapy*; D014927:Wolff-Parkinson-White Syndrome / Q000503:physiopathology / Q000628:therapy